Quality Improvement Care Bundles for Premature Birth
(ABC-QI Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Quality Improvement Care Bundles for Premature Birth?
Research shows that using care bundles, which are sets of practices done together, can improve patient outcomes. For example, a nutrition care bundle helped premature infants gain weight better, and care bundles in intensive care units have reduced infections. This suggests that care bundles can be effective in improving care quality in various settings.12345
Is the Quality Improvement Care Bundle generally safe for humans?
What makes the Quality Improvement Care Bundles for Premature Birth unique compared to other treatments?
The Quality Improvement Care Bundles for Premature Birth are unique because they use standardized sets of care practices, focusing on nutrition and respiratory support, to improve outcomes in premature infants. These bundles are evidence-based and aim to reduce complications like bronchopulmonary dysplasia (a lung condition) and improve growth, which is different from traditional treatments that may not use such comprehensive, structured approaches.246810
What is the purpose of this trial?
The ABC-QI Trial aims to implement collaborative quality improvement (QI) strategies to standardize care for 32-36 week infants in Level 2 and 3 Neonatal intensive care units (NICUs) across the province of Alberta. The investigators want to know if using validated quality improvement methods and evidence-based care bundles will decrease the duration of hospital stay and get babies home as quickly as possible.
Research Team
Jennifer Toye, MD
Principal Investigator
University of Alberta
Ayman Abou Mehrem, MD
Principal Investigator
University of Calgary
Eligibility Criteria
This trial is for preterm infants born between 32 to 36 weeks' gestation in Alberta's NICUs, as well as the healthcare staff working there. Infants with major birth defects or those needing surgery, and babies treated outside Alberta are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Control Arm
NICUs in the control arm conduct QI activities relevant to current practice without receiving the interventions
Intervention Arm
NICUs transition to the intervention arm and implement collaborative QI strategies including QI Team Building, QI Education, and care bundles
Follow-up
Participants are monitored for safety and effectiveness after discharge, including emergency room visits and rehospitalizations
Treatment Details
Interventions
- Collaborative networking
- Current practice- standard of care
- QI education
- QI mentoring
- QI Team Building
- Standardized care bundle- nutritional care
- Standardized care bundle- respiratory care
Standardized care bundle- nutritional care is already approved in Canada for the following indications:
- Care for moderate and late preterm infants in Level 2 and 3 NICUs
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Covenant Health, Canada
Collaborator
University of Alberta
Collaborator
Covenant Health
Collaborator
Alberta Health services
Collaborator